ERBB2 and breast cancer: A single-center prospective study from MD Anderson Cancer Center involved 40 patients with clinical T1-3N0-3M0 and TN or HER2-positive BC who were assessed as complete or partial remission by ultrasound or mammography after NCT and underwent fine-needle aspiration biopsy or coarse needle biopsy before the operation.